CN Patent

CN102596936A — 抗病毒化合物

Assigned to Gilead Pharmasset LLC · Expires 2012-07-18 · 14y expired

What this patent protects

本发明涉及抗病毒化合物、包含这种化合物的组合物、和包括给予这种化合物的治疗方法、以及涉及可用于制备这种化合物的方法和中间体。

USPTO Abstract

本发明涉及抗病毒化合物、包含这种化合物的组合物、和包括给予这种化合物的治疗方法、以及涉及可用于制备这种化合物的方法和中间体。

Drugs covered by this patent

Patent Metadata

Patent number: CN102596936A
Jurisdiction: CN
Classification: —
Expires: 2012-07-18
Drug substance claim: No
Drug product claim: No
Assignee: Gilead Pharmasset LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.